Motixafortide alone and in combination with natalizumab can support the collection of the large number of stem cells required ...

Key Highlights Motixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease enabling accelerated access to gene therapies 90% (9 of 10) of ...

Please provide your email address to receive an email when new articles are posted on . Most patients with sickle cell disease are not using disease-modifying therapies. DMT use increased nearly 10% ...

Most people with sickle cell disease who undergo allogeneic hematopoietic cell transplantation achieve favorable long-term ...

Experts call for consistent, specialist care throughout life to prevent complications and improve outcomes for people with ...

A class of drugs used for their ability to stop tumor cells from dividing is now under study for their potential to reduce the pain and damage caused by sickle cell disease, investigators report. The ...

As a parent with a child who has sickle cell disease, you are always on high alert. The “what if” stays with me, as it ...

More than a century after sickle cell disease was first diagnosed, the inherited blood disorder appears to be on the verge of a cure. That progress was kick-started, in part, by the Doris Duke ...

Five seemingly unconnected Black and ethnic minority Londoners discover they have superpowers in the hit Netflix series "Supacell". The link between them? They all suffer from sickle cell anaemia, a ...